UPLOAD Filing
Kairos Pharma, LTD.
Date: Jan. 15, 2026 · CIK: 0001962011 · Accession: 0000000000-26-000555
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-292686
Letter
January 15, 2026 John S. Yu, M.D. Chief Executive Officer Kairos Pharma, Ltd. 2355 Westwood Blvd., #139 Los Angeles CA 90064 Re:Kairos Pharma, Ltd. Registration Statement on Form S-3 Filed January 13, 2026 File No. 333-292686 Dear John S. Yu M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc:Megan J. Penick, Esq.
Show Raw Text
January 15, 2026
John S. Yu, M.D.
Chief Executive Officer
Kairos Pharma, Ltd.
2355 Westwood Blvd., #139
Los Angeles CA 90064
Re:Kairos Pharma, Ltd.
Registration Statement on Form S-3
Filed January 13, 2026
File No. 333-292686
Dear John S. Yu M.D.:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:Megan J. Penick, Esq.